Phosphorylation‐dependent and ‐independent functions of p130 cooperate to evoke a sustained G1 block

The retinoblastoma (pRb)‐related p130 pocket protein is a regulator of cell growth and differentiation, and a candidate tumour suppressor. Both pRb and p130 operate through interactions with cellular proteins, including the E2F transcription factors. While such interactions are controlled by phosphorylation of multiple sites of pRb, regulation of p130 remains poorly understood. We now identify 22 in vivo phosphorylation sites of p130, targeted by diverse kinases, and present evidence for three cyclin‐dependent kinase 4(6) [Cdk4(6)] specific phosphorylations, which appear critical for controlling the growth‐restraining activity of p130. When expressed in U2OS cells, the phosphorylation‐deficient mutant p130ΔCdk4, in which the Cdk4 specific sites were mutated to alanine residues, imposed a more sustained G1 arrest than a constitutively active pRbΔCdk, known to repress all cellular E2F activity. Experiments using p130ΔCdk4 and another phosphorylation‐deficient mutant, p130PM19A, with 19 phosphorylation sites mutated, revealed that the p130‐imposed G1 block reflects cooperative growth‐suppressive effects of phosphorylation‐regulated E2F binding and phosphorylation‐independent sequestration of cyclin E(A)–Cdk2 through the N‐terminal cyclin binding motif of p130.

[1]  R. Weinberg,et al.  The retinoblastoma protein and cell cycle control , 1995, Cell.

[2]  J. Nevins,et al.  The accumulation of an E2F-p130 transcriptional repressor distinguishes a G0 cell state from a G1 cell state , 1996, Molecular and cellular biology.

[3]  James M. Roberts,et al.  Cyclin E-CDK2 is a regulator of p27Kip1. , 1997, Genes & development.

[4]  J. Nevins,et al.  Identification of positively and negatively acting elements regulating expression of the E2F2 gene in response to cell growth signals , 1997, Molecular and cellular biology.

[5]  R. Weinberg,et al.  E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Nevins,et al.  E2F4 and E2F5 play an essential role in pocket protein-mediated G1 control. , 2000, Molecular cell.

[7]  S. Mittnacht,et al.  pRB phosphorylation mutants reveal role of pRB in regulating S phase completion by a mechanism independent of E2F , 1998, Oncogene.

[8]  B. Gallie,et al.  Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity , 1999, Molecular and Cellular Biology.

[9]  N. Dyson,et al.  Requirements for cell cycle arrest by p16INK4a. , 2000, Molecular cell.

[10]  Lingyun Zhu,et al.  Differential roles of two tandem E2F sites in repression of the human p107 promoter by retinoblastoma and p107 proteins , 1995, Molecular and cellular biology.

[11]  R. Bernards,et al.  E2F: a nodal point in cell cycle regulation. , 1997, Biochimica et biophysica acta.

[12]  M. Kitagawa,et al.  The consensus motif for phosphorylation by cyclin D1‐Cdk4 is different from that for phosphorylation by cyclin A/E‐Cdk2. , 1996, The EMBO journal.

[13]  T. Jacks,et al.  The retinoblastoma gene family in differentiation and development , 1999, Oncogene.

[14]  B. Dynlacht,et al.  Dual Cyclin-Binding Domains Are Required for p107 To Function as a Kinase Inhibitor , 1998, Molecular and Cellular Biology.

[15]  Jiri Bartek,et al.  Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex , 1999, Nature.

[16]  J. Wang,et al.  Inhibition of DNA synthesis by RB: effects on G1/S transition and S-phase progression. , 1998, Genes & development.

[17]  Sibylle Mittnacht,et al.  Differential Phosphorylation of the Retinoblastoma Protein by G1/S Cyclin-dependent Kinases* , 1997, The Journal of Biological Chemistry.

[18]  F. Rossi,et al.  Cdk2-dependent Phosphorylation and Functional Inactivation of the pRB-related p130 Protein in pRB(−), p16INK4A(+) Tumor Cells* , 2000, The Journal of Biological Chemistry.

[19]  N. Dyson,et al.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. , 1997, Genes & development.

[20]  A. Iavarone,et al.  E2F and Histone Deacetylase Mediate Transforming Growth Factor β Repression of cdc25A during Keratinocyte Cell Cycle Arrest , 1999, Molecular and Cellular Biology.

[21]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[22]  J. Wang Retinoblastoma protein in growth suppression and death protection. , 1997, Current opinion in genetics & development.

[23]  S. Reed,et al.  Cyclin E-induced S phase without activation of the pRb/E2F pathway. , 1997, Genes & development.

[24]  C. Anderson,et al.  The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. , 1991, The EMBO journal.

[25]  S. Mittnacht,et al.  Control of pRB phosphorylation. , 1998, Current opinion in genetics & development.

[26]  C. Wernstedt,et al.  Mutation of a Src phosphorylation site in the PDGF beta‐receptor leads to increased PDGF‐stimulated chemotaxis but decreased mitogenesis. , 1996, The EMBO journal.

[27]  R. Weinberg,et al.  Shared role of the pRB-related p130 and p107 proteins in limb development. , 1996, Genes & development.

[28]  X. Graña,et al.  Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. , 1995, Oncogene.

[29]  J. Harper,et al.  Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. , 1997, Molecular biology of the cell.

[30]  Jean Y. J. Wang,et al.  Differential Regulation of Retinoblastoma Protein Function by Specific Cdk Phosphorylation Sites (*) , 1996, The Journal of Biological Chemistry.

[31]  Y. Furukawa,et al.  Transcriptional repression of the E2F-1 gene by interferon-α is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes , 1999, Oncogene.

[32]  J. Minna,et al.  Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. , 2000, Cancer research.

[33]  Jie-Oh Lee,et al.  Structure of the retinoblastoma tumour-suppressor pocket domain bound to a peptide from HPV E7 , 1998, Nature.

[34]  W. Kaelin,et al.  Identification of a growth suppression domain within the retinoblastoma gene product. , 1992, Genes & development.

[35]  N. Tommerup,et al.  Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Pfeifer,et al.  In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression , 1995, Molecular and cellular biology.

[37]  R. Kerkhoven,et al.  Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. , 1995, Genes & development.

[38]  James M. Roberts,et al.  A new pathway for mitogen-dependent Cdk2 regulation uncovered in p27Kip1-deficient cells , 1999, Current Biology.

[39]  J. Bartek,et al.  The retinoblastoma protein pathway in cell cycle control and cancer. , 1997, Experimental cell research.

[40]  J. Bartek,et al.  p16INK4a, but not constitutively active pRb, can impose a sustained G1 arrest: molecular mechanisms and implications for oncogenesis , 1999, Oncogene.

[41]  W. Kaelin,et al.  Structural and functional contributions to the G1 blocking action of the retinoblastoma protein. (the 1992 Gordon Hamilton Fairley Memorial Lecture). , 1993, British Journal of Cancer.

[42]  G. Hannon,et al.  Isolation of the Rb-related p130 through its interaction with CDK2 and cyclins. , 1993, Genes & development.

[43]  B. Dynlacht,et al.  Copyright © 1997, American Society for Microbiology p130 and p107 Use a Conserved Domain To Inhibit Cellular , 1997 .

[44]  T. Kouzarides Histone acetylases and deacetylases in cell proliferation. , 1999, Current opinion in genetics & development.

[45]  J. Harbour,et al.  The Rb/E2F pathway: expanding roles and emerging paradigms. , 2000, Genes & development.

[46]  J. Bartek,et al.  Induction of S-phase entry by E2F transcription factors depends on their nuclear localization , 1997, Molecular and cellular biology.

[47]  D. Johnson,et al.  Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity. , 1995, Oncogene.

[48]  M. Rudnicki,et al.  Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene. , 1998, Development.

[49]  Jiri Bartek,et al.  Centrosome duplication in mammalian somatic cells requires E2F and Cdk2–Cyclin A , 1999, Nature Cell Biology.

[50]  X. Graña,et al.  Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth , 1998, Oncogene.

[51]  C. Wernstedt,et al.  Identification of the Major Phosphorylation Sites for Protein Kinase C in Kit/Stem Cell Factor Receptor in Vitro and in Intact Cells (*) , 1995, The Journal of Biological Chemistry.

[52]  K. Moberg,et al.  E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry , 1996, Molecular and cellular biology.

[53]  J. Harbour,et al.  Cdk Phosphorylation Triggers Sequential Intramolecular Interactions that Progressively Block Rb Functions as Cells Move through G1 , 1999, Cell.

[54]  J. Nevins,et al.  Distinct mechanisms control the accumulation of the Rb-related p107 and p130 proteins during cell growth. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[55]  M. Vooijs,et al.  Developmental defects and tumor predisposition in Rb mutant mice , 1999, Oncogene.

[56]  T. Hunter,et al.  Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. , 1991, Methods in enzymology.

[57]  A. Fattaey,et al.  CDK inhibition and cancer therapy. , 1999, Current opinion in genetics & development.

[58]  P. Whyte,et al.  Identification of a p130 domain mediating interactions with cyclin A/cdk 2 and cyclin E/cdk 2 complexes , 1997, Oncogene.

[59]  N. Dyson The regulation of E2F by pRB-family proteins. , 1998, Genes & development.

[60]  J. Bartek,et al.  Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16 , 1995, Nature.